bibliographic entry 11595239 [be/11595239]
https://w3id.org/oc/corpus/be/11595239

is a
content
  • Pao, W, Miller, VA, Politi, KA, Riely, GJ, Somwar, R, Zakowski, MF. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain, PLoS Med, 2005, 2, e73, PMID: 15737014
references